Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
2628.HK Stock Summary
Top 10 Correlated ETFs
2628.HK
In the News
2628.HK Financial details
Company Rating
Strong Buy
Market Cap
726.98B
Income
7.8B
Revenue
1072.97B
Book val./share
-
Cash/share
-
Dividend
0.53
Dividend %
5.35%
Employees
102.24K
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
32.95
Forward P/E
-
PEG
-11.19
P/S
0.62
P/B
0.58
P/C
-
P/FCF
2.21
Quick Ratio
32.32
Current Ratio
32.32
Debt / Equity
0.03
LT Debt / Equity
0.03
-
-
EPS (TTM)
1.27
EPS next Y
-
EPS next Q
-
EPS this Y
-36.67%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
23.3%
Revenue last 5Y
5.08%
Revenue Q/Q
641.33%
EPS Q/Q
-
-
-
-
-
SMA20
-3.27%
SMA50
-14.81%
SMA100
-15.79%
Inst Own
0%
Inst Trans
0%
ROA
-
ROE
2%
ROC
-
Gross Margin
100%
Oper. Margin
2%
Profit Margin
1%
Payout
399%
Shs Outstand
72.92B
Shs Float
72.92B
-
-
-
-
Target Price
-
52W Range
9.92-15.84
52W High
-33.67%
52W Low
+10.56%
RSI
32.3
Rel Volume
0.67
Avg Volume
27.61M
Volume
18.62M
Perf Week
-5.78%
Perf Month
-6.66%
Perf Quarter
-27.16%
Perf Half Y
-26.08%
-
-
-
-
Beta
0.885
-
-
Volatility
0.21%, 0.39%
Prev Close
-1.49%
Price
9.95
Change
-2.45%
2628.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 22.2 | 25.81 | 28.48 | 29.17 | 28.44 | |
Net income per share | 0.4 | 2.06 | 1.78 | 1.8 | 1.14 | |
Operating cash flow per share | 5.22 | 10.12 | 10.76 | 10.13 | 12.45 | |
Free cash flow per share | 4.53 | 9.72 | 10.49 | 9.94 | 12.34 | |
Cash per share | 32.6 | 39.35 | 45.01 | 52.71 | 66.01 | |
Book value per share | 11.26 | 14.29 | 15.92 | 16.93 | 15.43 | |
Tangible book value per share | 11.16 | 14.21 | 15.88 | 16.93 | 15.46 | |
Share holders equity per share | 11.26 | 14.29 | 15.92 | 16.93 | 15.43 | |
Interest debt per share | 0.86 | 2.25 | 2.21 | 2.23 | 1.92 | |
Market cap | 409.54B | 545.8B | 406.66B | 298.04B | 334.24B | |
Enterprise value | 378.88B | 550.62B | 407.24B | 293.46B | 255.99B | |
P/E ratio | 35.94 | 9.36 | 8.09 | 5.85 | 10.42 | |
Price to sales ratio | 0.65 | 0.75 | 0.51 | 0.36 | 0.42 | |
POCF ratio | 2.78 | 1.91 | 1.34 | 1.04 | 0.95 | |
PFCF ratio | 3.2 | 1.99 | 1.37 | 1.06 | 0.96 | |
P/B Ratio | 1.29 | 1.35 | 0.9 | 0.62 | 0.77 | |
PTB ratio | 1.29 | 1.35 | 0.9 | 0.62 | 0.77 | |
EV to sales | 0.6 | 0.75 | 0.51 | 0.36 | 0.32 | |
Enterprise value over EBITDA | 18.82 | 9.97 | 8.27 | 6.63 | 7.81 | |
EV to operating cash flow | 2.57 | 1.93 | 1.34 | 1.02 | 0.73 | |
EV to free cash flow | 2.96 | 2.01 | 1.37 | 1.04 | 0.73 | |
Earnings yield | 0.03 | 0.11 | 0.12 | 0.17 | 0.1 | |
Free cash flow yield | 0.31 | 0.5 | 0.73 | 0.94 | 1.04 | |
Debt to equity | 0.06 | 0.15 | 0.13 | 0.12 | 0.11 | |
Debt to assets | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | |
Net debt to EBITDA | -1.52 | 0.09 | 0.01 | -0.1 | -2.39 | |
Current ratio | 17.31 | 19.4 | 20.89 | 26.58 | 31 | |
Interest coverage | 4.25 | 11.96 | 11.76 | 6.97 | 5.65 | |
Income quality | 10.6 | 4.78 | 5.58 | 5.67 | 14.64 | |
Dividend Yield | 0.03 | 0.01 | 0.05 | 0.06 | 0.05 | |
Payout ratio | 1.03 | 0.08 | 0.41 | 0.36 | 0.57 | |
Sales general and administrative to revenue | 0.06 | 0.06 | 0.05 | 0.05 | 0.05 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.13 | -0.04 | -0.02 | -0.02 | -0.01 | |
Capex to revenue | -0.03 | -0.02 | -0.01 | -0.01 | 0 | |
Capex to depreciation | -7.41 | -2.61 | -1.45 | -1.04 | -0.58 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 10.11 | 25.75 | 25.24 | 26.2 | 19.85 | |
ROIC | 0.04 | 0.11 | 0.08 | 0.08 | 0.08 | |
Return on tangible assets | 0 | 0.02 | 0.01 | 0.01 | 0.01 | |
Graham Net | -70.41 | -77.44 | -88.63 | -102.58 | -103.54 | |
Working capital | 892.74B | 1075.48B | 1234.51B | 1453.27B | 1824.58B | |
Tangible asset value | 315.38B | 401.51B | 448.88B | 478.65B | 437.03B | |
Net current asset value | 1983.64B | 2183.47B | 2498.89B | 2894.34B | 2921.47B | |
Invested capital | 0.06 | 0.15 | 0.13 | 0.12 | 0.11 | |
Average receivables | 28.44B | 23.89B | 23.01B | 22.36B | 20.03B | |
Average payables | 52.61B | 56.59B | 60.26B | 59.45B | 58.82B | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 15.2 | 10.84 | 11.04 | 9.01 | 8.94 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 24.01 | 33.68 | 33.05 | 40.5 | 40.82 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.04 | 0.14 | 0.11 | 0.11 | 0.07 | |
Capex per share | -0.69 | -0.4 | -0.26 | -0.19 | -0.11 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 13.12 | 2.53 | 0 | |
Net income per share | 0 | 0 | 0.64 | 0.31 | 0 | |
Operating cash flow per share | 0 | 0 | 6.17 | 3.03 | 0 | |
Free cash flow per share | 0 | 0 | 6.15 | 3.02 | 0 | |
Cash per share | 0 | 0 | 72.11 | 101.7 | 0 | |
Book value per share | 0 | 0 | 16.52 | 16.86 | 0 | |
Tangible book value per share | 0 | 0 | 16.55 | 192.3 | 0 | |
Share holders equity per share | 0 | 0 | 16.52 | 16.86 | 0 | |
Interest debt per share | 0 | 0 | 3.27 | 0.3 | 0 | |
Market cap | 0 | 0 | 314.72B | 342.08B | 0 | |
Enterprise value | -64.82B | -78.25B | 365.3B | 195.19B | -144.72B | |
P/E ratio | 0 | 0 | 4.4 | 9.71 | 0 | |
Price to sales ratio | 0 | 0 | 0.86 | 4.77 | 0 | |
POCF ratio | 0 | 0 | 1.83 | 3.98 | 0 | |
PFCF ratio | 0 | 0 | 1.83 | 4 | 0 | |
P/B Ratio | 0 | 0 | 0.68 | 0.72 | 0 | |
PTB ratio | 0 | 0 | 0.68 | 0.72 | 0 | |
EV to sales | -0.35 | -0.76 | 1 | 2.72 | -0.27 | |
Enterprise value over EBITDA | 2.82K | 11.73 | 19.41 | 131.36 | 4.15 | |
EV to operating cash flow | -1.4 | -1.24 | 2.12 | 2.27 | -1.61 | |
EV to free cash flow | 1.38 | -1.27 | 2.13 | 2.28 | 8.61 | |
Earnings yield | 0 | 0 | 0.06 | 0.03 | 0 | |
Free cash flow yield | 0 | 0 | 0.55 | 0.25 | 0 | |
Debt to equity | 0.12 | 0.11 | 0.11 | 0.1 | 0.03 | |
Debt to assets | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
Net debt to EBITDA | 2.82K | 11.73 | 2.69 | -98.85 | 4.15 | |
Current ratio | 27.49 | 31 | 29.04 | 41.75 | 32.32 | |
Interest coverage | 0 | 0 | 1.45 | -0.04 | 0 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0.01 | 0 | 0 | |
Payout ratio | 4.36 | 5.73 | 0.19 | 0.18 | -1.01 | |
Sales general and administrative to revenue | 0.05 | 0.12 | 0.03 | 0.14 | 0.02 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -2.02 | -0.02 | 0 | -0.01 | -1.19 | |
Capex to revenue | -0.51 | -0.01 | 0 | -0.01 | -0.2 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 0 | 15.43 | 10.86 | 0 | |
ROIC | 0 | 0 | 0.11 | 0 | -0.05 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | 0 | 0 | -103.51 | 100.61 | 0 | |
Working capital | 1671.89B | 1824.58B | 2060.64B | 2813.42B | 2263.38B | |
Tangible asset value | 453.72B | 437.03B | 461.83B | 5450.47B | 443.13B | |
Net current asset value | 2930.96B | 2921.47B | 2858.18B | 2834.12B | 2972.25B | |
Invested capital | 0.12 | 0.11 | 0.11 | 0.1 | 0.03 | |
Average receivables | 25.11B | 9.85B | 70.78B | 72.71B | 78.41B | |
Average payables | 61.02B | 61.26B | 67.15B | 71.26B | 70.66B | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 17.14 | 29.95 | 29.58 | 22.56 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 5.25 | 3.01 | 3.04 | 3.99 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.01 | 0 | 0.04 | 0.02 | -0.05 | |
Capex per share | 0 | 0 | -0.03 | -0.02 | 0 |
2628.HK Frequently Asked Questions
What is China Life Insurance Company Limited stock symbol ?
China Life Insurance Company Limited is a CN stock and trading under the symbol 2628.HK
What is China Life Insurance Company Limited stock quote today ?
China Life Insurance Company Limited stock price is $9.95 today.
Is China Life Insurance Company Limited stock public?
Yes, China Life Insurance Company Limited is a publicly traded company.